已收盘 12-19 16:00:00 美东时间
+19.020
+2.54%
AbbVie and other drugmakers may announce U.S. drug pricing deals on Friday as the White House pushes lower prices and Medicare payment reforms.
12-18 23:14
Kymera Therapeutics released positive clinical results for KT-621 for atopic dermatitis and other allergic diseases.
12-08 22:54
Sanofi faces a surprise tax probe in France as Dupixent secures EU approval for treating chronic spontaneous urticaria.
11-26 02:30
Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lift Wall Street on Thursday.
11-21 01:43
Michael Burry's Scion Asset Management filed an updated 13F showing a new large bearish position in Palantir and Nvidia, among others.
11-04 07:17
Companies Reporting Before The Bell • PayPal Holdings (NASDAQ:PYPL) is expected...
10-28 19:11
美股周三早盘,标普500指数成份股再生元制药公司(Regeneron,REGN)股价上涨6.7%,该公司正见证其核心产品的收入增长,目前这一增长已抵消了其先前重磅药物收入的下降。分析师称再生元值得买入。 海量资讯、精准解读,尽在新浪财经APP 责任编辑:张俊 SF065
10-01 22:25
(来源:药剂Talks) 下一代肿瘤“药王”,极有可能诞生于PD-(L)1 Plus领域。 以K药为代表的PD-1单抗,开启了一代IO(肿瘤免疫治疗)时代,但...
09-04 07:52
(来源:药剂Talks) 下一代肿瘤“药王”,极有可能诞生于PD-(L)1 Plus领域。 以K药为代表的PD-1单抗,开启了一代IO(肿瘤免疫治疗)时代,但...
09-04 07:52